Management of erroneous subcutaneous injection of vincristine
| Errataetall: |
CommentIn: Leuk Lymphoma. 2021 Jun;62(6):1536-1537. - PMID 33353433 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 61(2020), 10 vom: 16. Okt., Seite 2530-2532 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
de Goycoechea, Diego [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
5J49Q6B70F |
|---|
| Anmerkungen: |
Date Completed 27.04.2021 Date Revised 23.06.2021 published: Print-Electronic CommentIn: Leuk Lymphoma. 2021 Jun;62(6):1536-1537. - PMID 33353433 Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2020.1772471 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310876893 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310876893 | ||
| 003 | DE-627 | ||
| 005 | 20231225141038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2020.1772471 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1036.xml |
| 035 | |a (DE-627)NLM310876893 | ||
| 035 | |a (NLM)32508194 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a de Goycoechea, Diego |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of erroneous subcutaneous injection of vincristine |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.04.2021 | ||
| 500 | |a Date Revised 23.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Leuk Lymphoma. 2021 Jun;62(6):1536-1537. - PMID 33353433 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antineoplastic Agents, Phytogenic |2 NLM | |
| 650 | 7 | |a Vincristine |2 NLM | |
| 650 | 7 | |a 5J49Q6B70F |2 NLM | |
| 700 | 1 | |a Dewarrat, Natacha |e verfasserin |4 aut | |
| 700 | 1 | |a Rothuizen, Laura E |e verfasserin |4 aut | |
| 700 | 1 | |a Matter, Maurice |e verfasserin |4 aut | |
| 700 | 1 | |a Nagy, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Locher, Gisèle |e verfasserin |4 aut | |
| 700 | 1 | |a Spertini, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Blum, Sabine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 61(2020), 10 vom: 16. Okt., Seite 2530-2532 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2020 |g number:10 |g day:16 |g month:10 |g pages:2530-2532 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2020.1772471 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2020 |e 10 |b 16 |c 10 |h 2530-2532 | ||